Search

Remibrutinib

The FDA approved remibrutinib on September 30, 2025 as the only oral, targeted treatment for chronic spontaneous urticaria.

Linseed oil

Linseed oil is a rich source of α-Linolenic acid extracted from the dried, ripened seeds of the flax plant *Linum usitatissimum*. … Linseed oil is particularly susceptible to polymerization reactions upon exposure to oxygen in air due to a high content of di- and triunsaturated esters.

Dodecyldimethylamine N-oxide

Sulforaphane

Sulforaphane is under investigation for the treatment of Autism Spectrum Disorder. It is a naturally occurring isothiocyanate found in high concentration in a variety of broccoli.

Nadifloxacin

Nadifloxacin has been used in trials studying the treatment of Acne Vulgaris.

Methamidophos

Methamidophos is under investigation in clinical trial NCT03223753 (Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia in First Remission).

Beclabuvir

Beclabuvir has been used in trials studying the treatment of Hepatitis C, Chronic.

Lofentanil

Lofentanil is an analog of fentanyl and is one of the most potent opioids available today.

Iodine povacrylex

Prolonged skin exposure could cause skin defatting manifested by the following signs/symptoms; localized redness, itching, drying and cracking of skin. … DuraPrep solution is indicated for use as a patient preoperative skin preparation, for the preparation of the skin prior to surgery and to help reduce bacteria that can potentially cause skin infection

Mexazolam

Mexazolam (CS-386) is a benzodiazepine indicated for the treatment of anxiety with or without psychoneurotic conditions. … [A184910] The use of benzodiazepines in the treatment of anxiety is generally a second line measure.[A184910]